Merit Medical Systems provides historical revenue by new product categories for 2022-2025

MERIT MEDICAL SYSTEMS INC

Total revenue grew from $1.151B in 2022 to $1.516B in 2025, with foundational revenue at $1.029B and therapeutic at $487M in 2025.
Therapeutic revenue increased 24% year-over-year in 2025, driven by cardiac therapies ($93.4M), endoscopy ($72.5M), and oncology ($96.8M).
Foundational revenue rose to $1.029B in 2025 from $862M in 2022, with access ($588.5M) and OEM ($167.1M) as top platforms.
Quarterly total revenue rose sequentially from $355M in Q1 2025 to $394M in Q4 2025, with therapeutic platform growing each quarter.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.